BioTuesdays Feature Articles | Life Sciences News

Feature

iBio spearheading plant-based biopharmaceuticals at CDMO plant

By Len Zehr iBio (NYSE American:IBIO) has developed an industry-leading plant-based gene-expression technology to rapidly produce high levels of proteins used for making biologics at its contract development and...

December 18, 2018

Feature

Canopy Health to expand clinical mandate with Constellation Brands investment

Canopy Health Innovations, the research subsidiary of Canopy Growth (TSX:WEED; NYSE:CGC) that focuses on the development of therapeutic and natural health cannabis products, will get a big boost from a blockbuster $5...

December 11, 2018

Feature

Zuga Medical readying U.S. rollout of ZugaLink cloud platform to support digital dentistry

Closely-held Zuga Medical expects to roll out its digital dental implant solution, known as ZugaLink, across the U.S. in 2019. “Digital dentistry is the future of dentistry, with computer-aided design (CAD), computer...

December 4, 2018

Feature

Penta Medical commercializing wearable cold laser therapy device for chronic and acute injuries

Closely-held Penta Medical is now on the sales and marketing trail, targeting sports teams, orthopedic doctors and physical therapists with its PentaVO device. The wearable cold laser therapy and data collection device...

November 27, 2018

Feature

TRACON Pharma gears for important near-term milestones

TRACON Pharmaceuticals (NASDAQ:TCON) is expected to report several important potential milestones over the next two quarters, including two randomized data points from its product development pipeline.

November 20, 2018

Feature

Robert Foster swinging for the fence again with ContraVir Pharma

Dr. Robert Foster is teeing up another possible home run as the new CEO of ContraVir Pharmaceuticals (NASDAQ:CTRV) and its lead programs for liver disease arising from chronic viral infection and NASH (non-alcoholic...

November 13, 2018

Feature

Trendlines cites hands-on approach to growth of its investment portfolio

With 11 years of progressive growth in the value of its expanding portfolio, The Trendlines Group (SGX:42T; OTCQX:TRNLY), an Israeli investment company, takes a very hands-on approach with its early-stage medical and...

November 6, 2018

Feature

In conversation with Dr. Femida Gwadry-Sridhar of Pulse Infoframe

As founder and CEO of closely-held Pulse Infoframe, a leading cloud-based healthcare data insights company, Dr. Femida Gwadry-Sridhar’s resume boasts a deep background as a pharmacist, epidemiologist and methodologist...

October 30, 2018

Feature

MagnetTx developing combined MRI and linac for cancer radiation therapy

By Len Zehr Closely-held MagnetTx Oncology Solutions filed a 510(k) application with the FDA in September for its Aurora RT device, which combines the accuracy of magnetic resonance imaging (MRI) with linear accelerator...

October 23, 2018

Feature

Rgenix’s discovery platform identifying novel RNA-regulated cancer targets

By Len Zehr Closely-held Rgenix has identified novel cancer targets regulated by microRNA pathways, which are key drivers of cancer progression, and developed first-in-class treatments that have the potential to...

October 16, 2018

Feature

Lobo Genetics enabling safe cannabis use with DNA testing

Closely-held Lobo Genetics is readying the initial launch in the current quarter of 2018 of its Lobo Cube DNA testing device to bring the science of cannabis genetics to doctors and consumers.

October 9, 2018

Feature

CHF Solutions expanding commercialization of Aquadex FlexFlow for fluid overload

By Len Zehr CHF Solutions (NASDAQ:CHFS) has expanded its U.S. commercial team to 13 sales territories for its Aquadex FlexFlow system, an ultrafiltration treatment for patients with fluid overload who have failed...

October 2, 2018

Feature

electroCore focused on U.S. launch of gammaCore for acute treatment of episodic cluster headaches and migraines

By Len Zehr With FDA approval in hand for its gammaCore Sapphire therapy for the acute treatment of episodic cluster headaches and migraines, electroCore (NASDAQ:ECOR) is now focused on commercialization and...

September 25, 2018

Feature

elminda BNA technology unlocking secrets of brain disorders

By Len Zehr Closely-held elminda’s Brain Networks Analytics (BNA) technology is going beyond genetics, imaging and behavioral tests to unlock brain functioning and how the brain changes over time, combining Big Data and...

September 18, 2018

Feature

Actinium Pharma developing targeted conditioning for bone marrow transplant

By Len Zehr Actinium Pharmaceuticals (NYSE American:ATNM) intends to improve bone marrow transplants (BMT) access and patient outcomes and treat cancers with high unmet medical needs by combining the precision of...

September 11, 2018

Feature

Ritter Pharma aims to have first FDA-approved treatment for lactose intolerance

By Len Zehr Ritter Pharmaceuticals’ (NASDAQ:RTTR) lead product candidate, RP-G28, which recently entered Phase 3 clinical trials, has the potential to become the first prescription therapy for lactose intolerance, a...

September 4, 2018

Feature

Vasomune finds nice fit in co-development pact for vascular leakage with AnGes

Closely-held Vasomune Therapeutics found the right partner last month in AnGes (TYO:4563) to co-develop its Vasculotide drug candidate for the treatment of diseases associated with blood vessel leakage and pulmonary...

August 28, 2018

Feature

Evoke Pharma’s Gimoti NDA targets female gastroparesis patients with novel delivery approach

By Len Zehr Evoke Pharma’s (NASDAQ:EVOK) discovery that its metoclopramide nasal spray, known as Gimoti, to treat symptoms of gastroparesis, a delayed emptying of stomach contents, reduced symptoms in women, but not in...

August 21, 2018

Feature

Pharnext platform taps genomic data, AI for new combination medicines

By Melane Sampson A new drug discovery paradigm, PLEOTHERAPY, developed by Pharnext SA (FR0011191287-ALPHA) is based on big genomic data, artificial intelligence, and rigorous experimental analysis that involves...

August 14, 2018

Feature

Exicure readies two clinical data readouts later this quarter

By Len Zehrs Exicure (OTCQB:XCUR) expects to report data around the end of the third quarter of 2018 from two Phase 1 clinical trials, one in mild-to-moderate psoriasis and one in healthy volunteers with its lead...

August 7, 2018

Feature

Perimeter pioneering high resolution wide-field tissue imaging for tumor specimens

By Len Zehrs Closely-held Perimeter Medical Imaging’s next-generation wide-field optical coherence tomography (OCT) technology for tumor tissue specimens has imaging resolution 10 times higher than ultrasound and 100...

July 31, 2018

Feature

ASLAN Pharma gears up for data rich second half

By Len Zehrs ASLAN Pharmaceuticals (NASDAQ:ASLN; TPEx:6497) expects to report topline and interim data in the second half of 2018 from up to four clinical trials with its lead drug candidate, varlitinib, for the...

July 24, 2018

iBio spearheading plant-based biopharmaceuticals at CDMO plant

Canopy Health to expand clinical mandate with Constellation Brands investment

Zuga Medical readying U.S. rollout of ZugaLink cloud platform to support digital dentistry

Penta Medical commercializing wearable cold laser therapy device for chronic and acute injuries

TRACON Pharma gears for important near-term milestones

Robert Foster swinging for the fence again with ContraVir Pharma

Trendlines cites hands-on approach to growth of its investment portfolio

In conversation with Dr. Femida Gwadry-Sridhar of Pulse Infoframe

MagnetTx developing combined MRI and linac for cancer radiation therapy

Rgenix’s discovery platform identifying novel RNA-regulated cancer targets

Lobo Genetics enabling safe cannabis use with DNA testing

CHF Solutions expanding commercialization of Aquadex FlexFlow for fluid overload

electroCore focused on U.S. launch of gammaCore for acute treatment of episodic cluster headaches and migraines

elminda BNA technology unlocking secrets of brain disorders

Actinium Pharma developing targeted conditioning for bone marrow transplant

Ritter Pharma aims to have first FDA-approved treatment for lactose intolerance

Vasomune finds nice fit in co-development pact for vascular leakage with AnGes

Evoke Pharma’s Gimoti NDA targets female gastroparesis patients with novel delivery approach

Pharnext platform taps genomic data, AI for new combination medicines

Exicure readies two clinical data readouts later this quarter

Perimeter pioneering high resolution wide-field tissue imaging for tumor specimens

ASLAN Pharma gears up for data rich second half

General

More